Diagnosis & Disease Information

Treatment of Lupus in ESRD Patients Beneficial

Close supervision by rheumatologists and the use of immunosuppressant drugs appear to improve the survival of lupus patients with end-stage renal disease. John Schieszer reports in today’s Medical Minute that this new research finding could reverse a long-standing clinical practice for nephrologists.

Treating SLE in ESRD May Boost Survival

Frequent follow-up with a rheumatologist and continued immunosuppressive treatment for systemic lupus erythematosus (SLE) in patients with end-stage renal disease (ESRD) improves their chances of survival, according to a study.

Next post in ERA Congress